pembrolizumab,Talabostat
merck,BioXcel Therapeutics
['pembro', 'crpc']
talabostat plus pembrolizumab exhibits activity in mcrpc with scnc phenotype #medpub #oncotwitter #meded #oncology 
#Oncology news from major publishers consolidated for a more streamlined industry news experience.🎗🗞